Joinn Laboratories and Biomere merged to form a new premier, global nonclinical contract research organization (CRO). The Joinn-Biomere merger creates a new and expanded North American business subsidiary greatly enhancing our global scale and international footprint, while complementing and expanding on a scientific portfolio in great demand. With locations on the east and west coast and China, we are ideally suited to support our clients’ needs.
Our personal approach is the fabric of who we are. We are truly driven to expedite your research journey. Review our CRO areas of expertise as well as our differentiators below:
- Competitive study start times
- Largest colony of NHPs available in New England
- Enhanced and rapidly growing ocular research program (U.S and China)
- East coast vivarium and headquarters near Boston (Worcester, MA)
- New west coast vivarium (San Francisco Bay area)
- Named in top 10 CROs 2020 (Pharma Tech Outlook Magazine)
- Chief Operations Officer named in top 10 best COOs 2020 (Industry Era Magazine)
- Dedicated study director; start-to-finish, study-to-study
- Dedicated client concierge to manage navigation of placement of studies in China
- Average cost savings of 30% on studies placed in China
- Multiple comprehensive facilities in China:
o Beijing
o Suzhou
o Wuzhou
o Chongqing
